Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study.

By C. Patterson, G. Dahlquist, É. Gyürüs, A. Green, G. Soltész. The Lancet, 2009

1,609 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Genetics, Surgery

View Paper: https://www.semanticscholar.org/paper/15db35131c6ffeb3080d18118ae7f9b6e3d2185a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. G. Bakris
2. Å. Lernmark
3. D. Nathan
4. A. King
5. J. Shaw
6. M. S. Kirkman
7. V. Basevi

In Genetics

1. D. Nathan
2. A. King
3. J. Shaw
4. M. S. Kirkman

In Surgery

1. G. Bakris
2. D. Nathan
3. A. King
4. J. Shaw
5. M. S. Kirkman

Citations in the corpus

• Obesity in autoimmune diseases: not a passive bystander. (2014, background): “For several decades, industrialized countries face an increased prevalence of immune-mediated diseases [1,2].”
• The use of animal models in diabetes research (2012, background): “Type 2 diabetes is the most common type of diabetes with prevalence in the United Kingdom of around 4%.”
• Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. (2019, background): “Incidence rates of T1D are also rising, contributing to the increase in diabetes prevalence [6,7].”
• Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2002, background): “Only about 15% of patients with newly diagnosed type 1 diabetes have a first-degree relative with the disease (294).”
• Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. (2002, background): “Only about 15% of patients with newly diagnosed type 1 diabetes have a first-degree relative with the disease (294).”
• Type 1 diabetes: etiology, immunology, and therapeutic strategies. (2011, background): “If present trends continue, doubling of new cases of T1D in European children younger than 5 years is predicted between 2005 and 2020, and prevalence of cases in individuals younger than 15 years will rise by 70% (328), characteristic of a left shift towards an earlier age (123).”
• Chapter 1: Epidemiology of Type 1 Diabetes (2010, neutral): “The increasing incidence of T1D throughout the world is especially marked in young children.(10,23) Registries in Europe suggest that recent incident rates of T1D were highest in the youngest age group (0 to 4 years).”